NCT00042250已完成不适用
Cell Cycle Kinetics in Vivo in Patients With Hematologic Malignancies Studied by Iododeoxyuridine and Bromodeoxyuridine Labelling
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 28
- 试验地点
- 2
研究概览
简要总结
To determine cell cycle parameters and changes after treatment, the labelling agent is given and a bone marrow aspiration is accomplished before treatment and after treatment for comparison. Participants must be undergoing concurrent therapy for hematologic malignancy.
详细描述
Cell cycle parameters include LI, Ts, Tc, T dpot, changes in these parameters, and differences between normal and leukemic cells in patients with hematologic malignancy prior to and following treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
撤回
2 期
Non-Viral TCR Gene TherapyEndocrine/NeuroendocrineGastrointestinal/Genitourinary CancersBreast CancerOvarian CancerNon-Small Cell Lung CancerNCT04102436National Cancer Institute (NCI)
尚未招募
Unknown
aboratory tests for identification of liver disease patients.CTRI/2024/05/067728Datta Meghe Institute of Higher Education and Research
Unknown
2 期
To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung CancerNon-small Cell Lung CancerNCT02029209Chia Tai Tianqing Pharmaceutical Group Co., Ltd.110
已完成
不适用
evels of hematological parameters and disease activity in patients with rheumatoid arthritisPatients with different phases of rheumatoid arthritis have different hematologic parameters.Disease activity, Hematological parameters, Remission, Rheumatoid arthritis.TCTR20210923003avamindradhiraj University325
撤回
不适用
Biochemical Approach to Measuring Surgical TraumaTotal Knee ReplacementNCT01037400Hamilton Health Sciences Corporation